Andere talen Eurocine Vaccines AB

Aandelen

EUCI

SE0015382155

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 18-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0348 ^SEK	+10,13%		+12,26%	-24,35%

30/05	Eurocine Vaccines AB (publ) rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 maart 2024	CI
28/02	Eurocine Vaccines AB (publ) rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	30/05
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	28/02
Certain Shares of Eurocine Vaccines AB are subject to a Lock-Up Agreement Ending on 15-FEB-2024.	15/02
Correction - Eurocine Vaccines discloses interim report for July - September 2023	28/11
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2023	28/11
Eurocine Vaccines discloses interim report for Juli - September 2023	28/11
Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	30-08-23
Eurocine Vaccines AB Reports Earnings Results for the Full Year Ended June 30, 2023	30-08-23
Eurocine Vaccines discloses interim report for July 2022 - March 2023	24-05-23
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	24-05-23
Eurocine Vaccines Wins SEK300,000 Grant from Merck KGaA	04-05-23
Certain Shares of Eurocine Vaccines AB are subject to a Lock-Up Agreement Ending on 17-APR-2023.	17-04-23
Eurocine Vaccines discloses half-year report for July - December 2022	28-02-23
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	28-02-23
Eurocine Vaccines to Develop Chlamydia Vaccine Candidate Using mRNA	18-01-23
Eurocine Vaccines decides to develop mRNA-based vaccine candidate against chlamydia	17-01-23
Eurocine Vaccines AB Decides to Develop mRNA-Based Vaccine Candidate Against Chlamydia	17-01-23
Outstanding results for Eurocine Vaccines' mRNA based HSV-2 candidate	21-12-22
Eurocine Vaccines : Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate	20-12-22
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2022	29-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Eurocine Vaccines AB

Aandelen

EUCI

SE0015382155

Andere talen

Filters